Zealand Pharma AS (ZLDPF)
116.06
-4.12
(-3.43%)
USD |
OTCM |
Nov 13, 16:00
Zealand Pharma Market Cap: 8.199B for Nov. 13, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 8.199B |
| November 12, 2024 | 8.490B |
| November 11, 2024 | 8.902B |
| November 08, 2024 | 8.599B |
| November 07, 2024 | 8.410B |
| November 06, 2024 | 8.853B |
| November 05, 2024 | 8.752B |
| November 04, 2024 | 8.724B |
| November 01, 2024 | 8.461B |
| October 31, 2024 | 8.124B |
| October 30, 2024 | 8.397B |
| October 29, 2024 | 8.397B |
| October 28, 2024 | 8.619B |
| October 25, 2024 | 8.619B |
| October 24, 2024 | 8.619B |
| October 23, 2024 | 8.447B |
| October 22, 2024 | 8.372B |
| October 21, 2024 | 8.237B |
| October 18, 2024 | 8.234B |
| October 17, 2024 | 8.077B |
| October 16, 2024 | 7.912B |
| October 15, 2024 | 8.078B |
| October 14, 2024 | 8.011B |
| October 11, 2024 | 8.079B |
| October 10, 2024 | 8.308B |
| Date | Value |
|---|---|
| October 09, 2024 | 8.124B |
| October 08, 2024 | 8.320B |
| October 07, 2024 | 8.130B |
| October 04, 2024 | 7.948B |
| October 03, 2024 | 8.170B |
| October 02, 2024 | 8.485B |
| October 01, 2024 | 8.690B |
| September 30, 2024 | 8.654B |
| September 27, 2024 | 8.691B |
| September 26, 2024 | 8.868B |
| September 25, 2024 | 9.365B |
| September 24, 2024 | 9.020B |
| September 23, 2024 | 9.029B |
| September 20, 2024 | 9.624B |
| September 19, 2024 | 9.465B |
| September 18, 2024 | 9.465B |
| September 17, 2024 | 9.557B |
| September 16, 2024 | 9.557B |
| September 13, 2024 | 9.703B |
| September 12, 2024 | 9.280B |
| September 11, 2024 | 9.363B |
| September 10, 2024 | 8.920B |
| September 09, 2024 | 8.867B |
| September 06, 2024 | 8.975B |
| September 05, 2024 | 8.802B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
481.42M
Minimum
May 11 2022
10.05B
Maximum
Aug 16 2024
2.554B
Average
1.452B
Median
Market Cap Benchmarks
| Novo Nordisk AS | 475.07B |
| Genmab AS | 13.76B |
| Ascendis Pharma AS | 7.532B |
| Galecto Inc | 9.074M |
| Evaxion Biotech AS | 9.594M |
Market Cap Related Metrics
| PS Ratio | 660.57 |
| PEG Ratio | -2.927 |
| Price to Book Value | 6.162 |
| Price | 116.06 |
| Earnings Yield | -2.10% |
| PEGY Ratio | -2.927 |